Braves star Jurickson Profar faces a potential 162-game ban over a possible second PED violation in under a year, stirring broad attention across baseball. But here’s where the story gets increasingly complex...
The Atlanta Braves designated hitter, a Curaçao native who has played for multiple clubs since his 2012 MLB debut, is reportedly confronting a long-term suspension after another positive test for a performance-enhancing drug. If confirmed, the discipline would sideline him for the entire regular season and exclude him from postseason play, a consequence that would reshape his team’s plans and Profar’s career arc.
Key timeline details include Profar’s previous 80-game suspension last season for testing positive for Chorionic Gonadotropin (hCG), which he publicly acknowledged and accepted as part of MLB’s joint drug prevention program. The newly alleged violation would mark a second offense within a short period, intensifying scrutiny from fans, analysts, and fellow players about PED policies and their enforcement.
ESPN was first to report the potential 162-game penalty, and the same outlets note that Profar will also be ineligible to participate in the World Baseball Classic, where he had been slated to represent the Netherlands. The WBC setback adds an international dimension to the impact of the potential suspension, affecting national pride as well as professional prospects.
Profar’s representatives have said he intends to pursue a grievance through MLB’s players’ association to challenge the discipline. The process would involve baseball’s independent arbitrator, Martin F. Scheinman, a path familiar to players seeking to appeal league decisions. Commentators and fans will watch closely how this grievance unfolds and whether new evidence or interpretations of the testing procedures emerge.
Profar’s on-field stint with the Braves last season included 80 games with a .245 average and 14 home runs, underscoring the potential loss of a veteran contributor if the suspension stands. His career has spanned stints with the Texas Rangers, San Diego Padres (where he earned an All-Star berth in 2024), Oakland, and Colorado, painting a picture of a seasoned, versatile player whose trajectory could be markedly affected by this dispute.
As updates continue to come from ESPN and other outlets, this case raises broader questions about PED testing, the fairness of penalties, and how leagues balance competitive integrity with player rights. Do you think the punishment fits multiple offenses within a short timeframe, or should extenuating circumstances influence the outcome? Share your thoughts in the comments.
Note: This article includes initial reporting from multiple sources, with further details likely to emerge as the grievance process unfolds.
